SF2523 is primarily utilized in research settings as a potent inhibitor targeting specific kinases involved in cellular signaling pathways. Its application is significant in studying cancer biology, as it helps in understanding the role of these kinases in tumor growth and progression. Researchers use SF2523 to explore potential therapeutic strategies by blocking these pathways, which are often dysregulated in various cancers. Additionally, it aids in the development of targeted therapies by providing insights into the molecular mechanisms of kinase inhibition. Its use is confined to laboratory studies and preclinical research, contributing to the advancement of oncology and molecular biology.